The Needlestick Safety and Prevention Act (HR 5178), signed into law on November 6, 2000, was designed to protect the 8 million healthcare workers in the United States from injuries caused by needles and other sharp medical devices. This new federal law authorized the Occupational Safety and Health Administration (OSHA) to revise the bloodborne pathogens standard to require employers to identify, evaluate, and make use of effective, safer medical devices, and applies to any facilities where employees may be exposed to blood or other potentially infectious material, including home care and hospice organizations.
Since publication of the final rule of the bloodborne pathogens standard in December, 1991 a home care or hospice employee's risk for contracting a bloodborne disease during the course of providing patient care has been significantly reduced. Yet, occupational exposure to bloodborne pathogens from accidental sharps injuries in all healthcare settings has continued to be a serious problem. The exact number of accidental sharps injuries sustained by home care or hospice employees is not known; however, current estimates indicate that 590,000 accidental sharps injuries are sustained annually by healthcare workers in all healthcare settings (OSHA, 1999) . This article reviews the historical events behind the legislation and discusses the modifications to the existing bloodborne pathogens standard and their implications for home care and hospice organizations.
Out With the Old
In December 1991, when the final rule for the bloodborne pathogens standard was published, little data on the efficacy of safer devices were available. In addition, the choice of safer devices was limited. The original bloodborne pathogen standards essentially stated that home care and hospice organizations should be evaluating safety devices, but left a great deal of flexibility in whether their use was adopted.
Since then, there has been a substantial increase in the number and assortment of effective safety devices such as needleless systems and sharps with engineered sharps injury protections available to home care, hospice, and other healthcare organizations. Numerous studies have demonstrated that when safety medical devices are part of an overall bloodborne pathogens riskreduction program, there is a reduction in accidental sharps' injuries. The Centers for Disease Control and Prevention has estimated that 62% to 88% of the sharps injuries could potentially be © 650-7414; fax: (770) 650-7415; email: mmf@mindspring.com prevented by the use of safer medical devices, depending on the type of device used and the procedure involved (OSHA, 1999 For example, in several states, the needle safety laws require that needlesticks be reported to a state agency. If a state's needle safety law has fewer requirements than the federal law, the federal law's requirements also must be followed. As a guiding principle, the most restrictive law (i.e., either state or federal) must always be followed in practice.
In With the New When the legislators drafted the federal Needlestick Safety and Prevention Act, they incorporated much language and content of OSHA's November, 1999 compliance directive (CPL 202.44D) regarding requirements for the use of safety devices. As a result, the bill requires healthcare facilities under the federal OSHA to use safety-engineered devices as a primary engineering control to prevent occupational exposures to bloodborne pathogens in the work setting.
Modifications to the Bloodborne Pathogen Standard
The Needlestick Safety and Prevention Act required that the bloodborne pathogens standard be revised. The following is a summary of the standard's modifications, along with suggested actions to take to meet the new requirements:
Modification to the Definitions
The definition of "engineering controls" within the bloodborne pathogen standard now includes additional examples of controls of safer medical devices, such as sharps with engineered sharps injury protections and needleless systems (Needlestick Safety and Prevention Act of , Pub. L. No. 106-430, 114 Stat. 1901 [Nov. 6, 2000 ).
The term "Sharps with Engineered Sharps Injury Protections" has been added to the definitions noted within the bloodborne pathogen standard and is defined as: "A nonneedle sharp or a needle device used for withdrawing body fluids, accessing a vein or artery, or administering medications or other fluids, with a built-in safety feature or mechanism that effectively reduces the risk of an exposure incident" (Needlestick Safety and Prevention Act of , Pub. L. No. 106-430, 114 Stat. 1901 [Nov. 6, 2000 ).
The term "Needleless Systems" was added to the definitions noted with the bloodborne pathogen standard and defined as:
"A device that does not use needles for: the collection of bodily fluids or withdrawal of body fluids after initial venous or arterial access is established; the administration of medication or fluids; or any other procedure involving the potential for occupational exposure to bloodborne pathogens due to percutaneous injuries from contaminated sharps" (Needlestick Safety and Prevention Act of , Pub. L. No. 106-430, 114 Stat. 1901 (Nov. 6, 2000 .
A C T I O N
1. Review the home care or hospice organization's existing exposure control plan and modify the content to reflect the new/modified definitions.
Modification of the Exposure Control Plan
Exposure control plans are to be reviewed and updated to:
• reflect changes in technology that eliminate or reduce exposure to bloodborne pathogens, and • document annually consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure (Needlestick Safety and Prevention Act, 2000).
1. Document the revision to the exposure control plan to reflect the plan and timetable for evaluating, selecting, and implementing safety-engineered devices in all device categories with a potential for bloodborne pathogen exposure. 2. Record the procedure for evaluating and documenting the circumstances surrounding an exposure incident in the exposure control plan. 3. Implement the procedures for documenting and evaluating an exposure incident as identified in the exposure control plan.
A C T I O N
On an annual basis: 1. Document the review of the exposure control plan. 2. As necessary, revise the exposure control plan to reflect changes/updates in commercially Even if the home care or hospice organization is providing safety devices, be prepared to defend their effectiveness against the latest devices being introduced; an OSHA compliance officer may want to review that analysis.
New Sharps Injury Log Requirement
A home care or hospice organization is now mandated to establish and maintain a sharps injury log to record percutaneous injuries from contaminated sharps, as the previous OSHA 2000 log did not sufficiently reflect injuries that may involve exposure to bloodborne pathogens. The documentation maintained in the sharps injury log must be recorded and maintained in a way that protects the confidentiality of the injured employee. Minimally, the sharps injury log must contain: If an OSHA inspection occurs, copies of the home care and hospice organization's documentation on exposure incidents will be requested to determine if compliance has been met.
Solicitation of Input From Nonmanagerial Employees
A new section added to the bloodborne pathogen standard requires a home care or hospice organization to solicit input from nonmanagerial employees responsible for direct patient care-who are potentially exposed to injuries from contaminated sharps-in the identification, evaluation, and selection of effective engineering and work practice controls. The exposure control plan must document their participation (Needlestick Safety and Prevention Act, 2000).
A C T I O N
Establish a multidisciplinary team that includes clinical management and direct patient care providers potentially exposed to injuries from contaminated sharps to:
1. coordinate the activities of sharps injury prevention program to include the development or revision of a plan for selection, evaluation, and implementation of safety-engineer safety devices and needless systems; 2. gather information on the current use and availability of safety devices; 3. collect data and identify sharps devices in use with the greatest risk of exposure to bloodborne pathogens to be replaced; 4. identify, evaluate, and select safety-engineered sharps devices with protective features that retract, blunt, or otherwise shield the sharp point or edge after use and needless systems; 5. meet with product vendors to identify and choose safety devices to pilot test; 6. pilot-test safety devices for their effectiveness in patient care, reducing injuries, and ease of use; 7. select safety devices to replace targeted devices; 8. educate and train staff on the use of safety devices, needless systems, and safer work practices; 9. replace existing devices with safety devices as soon as possible after training; 10. develop strategies to ensure compliance with the use of safety devices and needless systems; 11. collect data and periodically evaluate the effectiveness of safety devices and needless systems in reducing the risk of injury from
• supplying personal protective equipment for the employee's use in the home; • providing safety devices to employees (e.g., sharps with "engineered sharps injury protection," needleless devices, blunt needles, plastic capillary tubes), and training employees to use the devices properly; • maintaining and updating the exposure control plan; • offering hepatitis B vaccinations; • providing postexposure evaluation and follow-up;
• maintaining a sharps injury log; and • providing initial and ongoing employee education.
To avoid an OSHA citation related to the use of engineering controls or safety devices, safety devices must be available for the employee's use in the home and the employee must have received prior trained in how to use the devices. The safety devices may be provided to the staff member on an individual basis and stored in the staff's supply bag taken into the home or the devices may be left in the home for the staff's use.
Effective Date
The Needlestick Safety and Prevention Act (HR 5178) was signed into law on November 6, 2000. Following the passage of the bloodborne pathogen standard in 1991, both the dental and home health industries sought exemption from the rule. The American Dental Association v. Martin decision granted a limited exemption to the home care industry (Rhinehart & Friedman, 1999) . The court held that OSHA had not adequately considered feasibility problems for home care providers, where employees work at sites that the employer does not control. As a result, OSHA may not cite a home care and hospice organization for site-specific violations such as:
• housekeeping requirements (e.g., maintenance of a clean and sanitary work site), • handling and disposal of regulated waste, • ensuring the use of personal protective equipment, • ensuring that specific work practices are followed (e.g., hands are washed with running water), and • ensuring the use of engineering controls (e.g., safety devices).
OSHA may cite a home care or hospice organization for failure to comply with all nonsite-specific requirements of the standard such as:
